14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 8th May 2024 CTMX stock ended at $4.19. This is 2.95% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 10.95% from a day low at $3.79 to a day high of $4.21.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Jul 05, 2016 $10.32 $10.32 $9.54 $10.02 47 300
Jul 01, 2016 $10.22 $10.63 $10.01 $10.38 107 100
Jun 30, 2016 $9.93 $10.25 $9.79 $10.21 74 300
Jun 29, 2016 $9.88 $9.95 $9.39 $9.84 74 900
Jun 28, 2016 $9.46 $9.84 $9.38 $9.71 77 100
Jun 27, 2016 $9.77 $10.00 $9.15 $9.30 177 700
Jun 24, 2016 $9.10 $10.45 $9.10 $9.83 1 480 000
Jun 23, 2016 $9.50 $9.91 $9.45 $9.64 104 700
Jun 22, 2016 $9.59 $9.94 $9.38 $9.50 68 100
Jun 21, 2016 $9.47 $9.65 $9.10 $9.63 77 200
Jun 20, 2016 $9.34 $9.64 $9.22 $9.44 69 900
Jun 17, 2016 $10.00 $10.00 $9.25 $9.25 201 500
Jun 16, 2016 $9.94 $10.11 $9.67 $10.05 89 728
Jun 15, 2016 $10.13 $10.45 $9.93 $10.06 78 569
Jun 14, 2016 $9.97 $10.25 $9.76 $10.08 120 064
Jun 13, 2016 $10.15 $10.49 $9.98 $10.03 90 443
Jun 10, 2016 $9.90 $10.30 $9.90 $10.17 70 222
Jun 09, 2016 $10.03 $10.31 $9.93 $10.04 137 631
Jun 08, 2016 $10.00 $10.20 $9.81 $10.16 91 811
Jun 07, 2016 $9.92 $10.40 $9.85 $9.99 67 545
Jun 06, 2016 $10.00 $10.25 $9.52 $10.00 282 384
Jun 03, 2016 $10.85 $11.10 $10.58 $10.85 81 174
Jun 02, 2016 $10.61 $11.11 $10.55 $10.78 174 238
Jun 01, 2016 $10.61 $10.98 $10.61 $10.70 95 835
May 31, 2016 $10.43 $11.06 $10.43 $10.80 256 496
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT